We aimed to determine whether frailty, a validated geriatric construct of increased vulnerability to physiologic stressors, predicts mortality in liver transplant candidates. Consecutive adult outpatients listed for liver transplant with laboratory Model for End-Stage Liver Disease (MELD) ! 12 at a single center (97% recruitment rate) underwent four frailty assessments: Fried Frailty, Short Physical Performance Battery (SPPB), Activities of Daily Living (ADL) and Instrumental ADL (IADL) scales. Competing risks models associated frailty with waitlist mortality (death/delisting for being too sick for liver transplant). Two hundred ninety-four listed liver transplant patients with MELD ! 12, median age 60 years and MELD 15 were followed for 12 months. By Fried Frailty score !3, 17% were frail; 11/51 (22%) of the frail versus 25/243 (10%) of the not frail died/were delisted (p ¼ 0.03). Each 1-unit increase in the Fried Frailty score was associated with a 45% (95% confidence interval, 4-202) increased risk of waitlist mortality adjusted for MELD. Similarly, the adjusted risk of waitlist mortality associated with each 1-unit decrease (i.e. increasing frailty) in the Short Physical Performance Battery (hazard ratio 1.19, 95% confidence interval 1.07-1.32). Frailty is prevalent in liver transplant candidates. It strongly predicts waitlist mortality, even after adjustment for liver disease severity demonstrating the applicability and importance of the frailty construct in this population.
Introduction
Every year, one in five patients on the liver transplant waitlist in the United States will die or become too sick for transplantation (1) . Although all candidates are prioritized for liver transplant by their risk of waitlist mortality as predicted by the laboratory-based Model for End-Stage Liver Disease (MELD) score (2) , 84% of those who died or were delisted for being too sick for transplant received at least one liver offer-with a median of five liver offers (all of which were refused by the transplant clinician or patient)prior to their death or delisting (3) . This suggests that there are important unmeasured donor and/or recipient factors other than the MELD score that are being incorporated into the decision to proceed with transplantation.
One of the recipient factors of importance is the transplant clinician's assessment of the patient's global health status, which may be conceptualized as the patient's vulnerability to stresses while on the waitlist (i.e. waitlist mortality) combined with his or her vulnerability to poor outcomes after transplant surgery (i.e. perioperative risk). In patients with cirrhosis, this ''state of health'' is influenced not only by liver disease severity which is well-captured by the MELD score, but by factors such as age, muscle mass, nutritional status and nonliver related co-morbidities that also contribute to waitlist outcomes but are not captured by the MELD score. There is robust rationale for the application of this clinical judgment, as several studies have shown that clinicians can predict outcomes in hospitalized or elderly patients (4) (5) (6) (7) . However, while inclusion of clinical assessment to liver transplant decisions may be justified, it is subjective and, as such, may differ from one clinician to another and lacks transparency. Moreover, components of this assessment are likely neither associated with nor validated to predict transplantrelated outcomes. Less charitably, this assessment may incorporate inappropriate factors, including age, sex, race and/or socioeconomic status. recognized as a crucial determinant of health outcomes, and is generally operationalized as frailty. While there are several measures of frailty that are used in geriatrics, all definitions seek to identify patients who are at risk for adverse outcomes in the setting of stressors such as acute medical illness, hip fracture or surgery. One of the most widely used definitions of frailty, the Fried Frailty phenotype (8) , conceptualizes frailty as a distinct clinical syndrome characterized by five domains suggesting decreased physiologic reserve. Other definitions of frailty are more expansive, and often view frailty in the context of functional status deficits and/or disability. Importantly, these multiple definitions of frailty have been operationalized as objective, validated measures (8-11) that have important prognostic value and can predict morbidity and mortality in both geriatric and surgical populations. Moreover, these measures can substantially enhance the predictive ability of traditionally used risk indices such as the American Society of Anesthesiologists score or Lee's revised cardiac index (12, 13) .
We hypothesized that this concept of frailty could be applied to patients with cirrhosis awaiting liver transplantation, a population at increased risk for accelerated functional decline, to similarly predict clinically relevant outcomes independent of liver disease severity. Therefore, we designed the Frailty Assessment in Liver Transplant Candidates Study (FrAI-LT Study) to measure frailty in liver transplant candidates using measures of physiologic reserve and functional status. In this particular study, we aimed to assess the prevalence and degree of frailty in liver transplant candidates and evaluate the association between these measures and waitlist mortality.
Methods

Study population
The FrAI-LT Study is an ongoing prospective cohort study of all adult (!18 years) patients with cirrhosis who are actively listed for liver transplantation at the University of California, San Francisco (UCSF). Patients were enrolled during an outpatient visit to the UCSF Liver Transplant Clinic, independent of their waitlist date; therefore, patients who were never seen as an outpatient at UCSF were not included in this study. In order to ensure an adequate number of events during the follow-up period, only candidates with a MELD score !12 were included. Patients were excluded if they had severe hepatic encephalopathy, as defined by the time to complete the Numbers Connection Test (14) of >120 sec, as this may impair the patient's ability to provide signed informed consent and comply with study procedures. Patients who had undergone a prior transplant were also excluded. In total, 304 patients were asked to participate in this study; while the number of patients who are actively awaiting liver transplant at UCSF is dynamic, there are currently approximately 300 actively waitlisted patients (15) . Of the 304 patients who were asked to participate, 294 (97%) consented and enrolled in the study.
Study procedures and data collection
At enrollment, all patients underwent frailty testing using four measures listed in Table 1 : Fried Frailty Instrument, Short Physical Performance Battery, Activities of Daily Living (ADL) Scale and Instrumental Activities of Daily Living Scale (IADL) at a single time point in the outpatient clinic. The actual instruments and grading systems used are shown in the Appendix. Given the overlap of testing of gait speed between the Fried Frailty Instrument and the Short Physical Performance Battery, only one walk test (4 m) was administered, but scored based on the number of meters per second for each instrument.
At the time of the frailty assessment, information regarding demographics, medical co-morbidities (e.g. hypertension, diabetes and coronary artery disease), degree of ascites and laboratory tests were collected from the patient's electronic health record. Hepatic encephalopathy was classified as none/mild versus moderate based on the patient's performance on the Numbers Connection Test Score of < or >60 sec, respectively.
Statistical analysis
The primary predictor was frailty, as assessed by the Fried Frailty Instrument. This was selected as the primary predictor given its construct validity in general surgical and kidney transplant patients (12, 16) , whom we felt were most similar to the liver transplant population. Subjects were classified as ''frail'' if they scored !3 on the Fried Frailty Instrument, using the same cutoffs that were used in the original study by Fried et al of 6000 community-dwelling elderly men and women enrolled in the Cardiovascular Health Study (8). Self-report Activities that allow an individual to live independently 8-0 Assesses difficulty with performing the activity Differences in baseline characteristics by frail status were compared using chi-square or Wilcoxon rank sum tests for categorical and continuous variables, respectively. Secondary predictors included frailty as assessed by the Short Physical Performance Battery, ADL Scale and IADL Scale.
The primary outcome in this study was waitlist mortality, defined as death prior to liver transplantation or delisting for being too sick for transplant. Patients who were delisted for reasons other than being too sick (e.g. substance abuse, nonadherence) were censored from the FrAI-LT Study at the time of waitlist removal.
In order to identify a subgroup of patients who might benefit most from frailty assessment in clinical practice, we evaluated rates of waitlist mortality by frail status (defined as a Fried Frailty score !3) and MELD categories, using the 75%ile MELD score for the cohort as the MELD cutoff. Competing risks analysis evaluated the association between frailty measures and waitlist mortality with liver transplant as the competing risk. To reduce the risk of overfitting models, only bi-variate and tri-variate analyses were performed using variables that may conceptually confound the association between frailty and waitlist mortality, following the general rule-of-thumb of allowing one predictor for every 10 events. A cutoff p-value <0.05 was used to determine statistical significance.
The UCSF Institutional Review Board approved this study. STATA 1 v12 (College Station, TX) was used for all statistical analyses. 
Results
Baseline characteristics of the cohort A total of 294 liver transplant waitlist candidates with MELD ! 12 were included in the analyses. Baseline characteristics of the cohort are shown in On the Short Physical Performance Battery, the median (IQR) score was 11 (9) (10) (11) (12) , with 73% able to complete all three balance tests for 10 sec each and 43% able to complete five chair stands within 11.1 sec. With respect to the disability scales, 76% and 57% reported no difficulty with completing all six ADLs by the ADL Scale and all 8 IADLs by the IADL Scale.
Characteristics associated with frailty
The primary predictor in this study was frailty as assessed by the Fried Frailty Instrument. Baseline characteristics among the not frail versus frail subjects are shown in Table 2 , columns B and C, respectively. The two groups were similar with respect to age, gender, race/ethnicity, etiology of liver disease, body size and proportion with HCC (p > 0.05). Frail patients had higher MELD scores, sodium, rates of mild/moderate and severe ascites, and rates of moderate hepatic encephalopathy (p < 0.05).
Frailty and outcome
By the end of follow-up, 36/294 (12%) died/were delisted for being too sick, 71 (24%) underwent liver transplant and 14 (5%) were removed from the waitlist for other reasons; 173/294 (59%) were actively waiting on the list at the end of the study period. The proportion of those who died/were delisted differed significantly by frail status: 11/51 (22%) frail versus 25/243 (10%) not frail (p ¼ 0.03).
Among the entire cohort, 51/294 (17%) were classified as frail (Fried Frailty score !3), 91/294 (31%) scored <9 on the Short Physical Performance Battery, 24% had difficulty with !1 ADL and 43% had difficulty with !1 IADL. Table 3 shows the scores on the four frailty measures by outcome (e.g. died/delisted, transplanted, waiting, other reason for removal). Patients who died/were delisted compared with those who were transplanted, still waiting or removed for Removed from the waitlist for reasons other than death, transplant or being too sick for transplant (i.e. substance abuse, medical nonadherence). 3 By the Kruskal-Wallis test. 4 The third component is gait speed in meters per second, which is listed above under the Fried Frailty Instrument. 5 Number of items in which the patient was independent.
other reasons displayed higher rates of frailty as demonstrated by a higher Fried Frailty score (p < 0.01), and higher degrees of physical inactivity (p ¼ 0.01). They also demonstrated higher rates of functional impairment by the Short Physical Performance Battery (p < 0.01) ( Table 3) .
Given the conceptual association between frailty and liver disease severity, we evaluated the proportion of patients that achieved a waitlist event by MELD score using MELD 18, the 75%ile cut-point for the cohort, and frailty status. Among those with MELD < 18, 5/22 (23%) who were classified as frail died/were delisted compared to 15/164 (9%) of the nonfrail, and among those with MELD ! 18, 6/26 (23%) frail patients and 10/63 (16%) nonfrail patients died/were delisted (p ¼ 0.07 for the comparison of all four groups) ( Figure 1 ).
With respect to the primary predictor (Fried Frailty score), univariable competing risks analysis revealed that a 1-unit increase in Fried Frailty score was associated with a 50% increased risk of waitlist mortality (p ¼ 0.01; Table 4 ). The hazard ratio (HR) associated with the Fried Frailty score did not change substantially after adjustment for MELD score, MELD and age, MELD and sodium, or MELD and hepatic encephalopathy as characterized by the Numbers Connection Test score in seconds (Table 4 ). Competing risks models evaluating the association between the Short Physical Performance Battery, a secondary predictor, and waitlist mortality produced similar results (HR 1.20, p < 0.01) ( Table 4 ). Although every unit increase in the IADL scale was significantly associated with waitlist mortality in unadjusted analysis (HR 1.17, p ¼ 0.03), adjustments for confounders in bi-and tri-variate models attenuated these differences (Table 4 ).
Discussion
The implementation of the MELD-based liver allocation system in the United States in 2002 has been heralded for its objectivity, fairness and success in reducing waitlist mortality (17) . Although the MELD score can accurately predict 90-day waitlist mortality for the vast majority of cirrhotics (18) , there are clearly certain waitlist candidates whose mortality risk is underestimated by MELD. We Performance-based and self-report instrument that includes five domains (gait speed, exhaustion, physical activity, unintentional weight loss and weakness). Range 0 (not frail) to 5 (frail). 2 Performance-based instrument that consists of three tests: repeated chair stands, balance testing and gait speed. Range 0 (frail) to 12 (robust). 3 Self-report instrument that asks about of daily self-care activities (e.g. bathing, feeding). Range 0 (dependent) to 6 (independent). 4 Self-report instrument that asks about activities necessary for an individual to live independently (e.g. preparing meals, doing laundry). Range 0 (dependent) to 12 (independent).
hypothesize that progressive under-nutrition, sarcopenia and functional decline-three components that are arguably the sine qua non of advanced cirrhosis-impact mortality in ways that are not fully captured by total bilirubin, international normalized ratio and creatinine.
In this study, we introduce tools to identify a subgroup of candidates that might be particularly vulnerable to adverse outcomes on the liver transplant waitlist. Borrowing the concept of frailty from geriatrics, we found that four common measures of physical frailty can be utilized to predict waitlist mortality in cirrhotics with a minimum MELD score of 12.
While patients displaying the frail phenotype, as defined by a Fried Frailty score !3, had statistically significantly higher MELD scores and rates of ascites and hepatic encephalopathy, our analyses demonstrated a robust, independent association between frailty and mortality even after adjustment for liver disease severity. The construct validity of frailty in liver transplant candidates was further strengthened by the qualitatively similar associations we observed between the Short Physical Performance Battery, a well-established metric of physical function, and waitlist mortality. Importantly, the measures of physical frailty that we tested in this study offer distinct advantages over other measures that must be assessed in an exercise physiology laboratory (e.g. cardiopulmonary exercise testing, isokinetic muscle testing) or by an imaging study (e.g. psoas muscle area) in that they can be performed quickly, repeatedly, and in a clinic setting without costly equipment or specialized technicians.
What exactly do these frailty measures capture? As described in the geriatrics literature, frailty is a distinct clinical state of increased vulnerability to health stressors and decreased physiologic reserve that leads to adverse health outcomes, including disability, short-and long-term institutionalization, and ultimately mortality (8, 19) . Although the underlying pathophysiology remains elusive, it is believed to result from the aggregate decline of numerous systems including, but not limited to, neuromuscular, inflammatory, skeletal and endocrine systems (20) . For patients with cirrhosis, the liver failure itself inevitably drives this process; there is obvious overlap between the manifestations of synthetic liver dysfunction and those of frailty. But, as anyone who has cared for these patients can attest to, there are individuals whose co-morbidities, under-nutrition, sarcopenia and functional decline appear to exceed the severity of their liver disease. We have conceptualized that the combination of these factors-that is frailty-not only worsens with liver disease severity but contributes to waitlist mortality independent of disease severity (Figure 2 ).
To an extent, certain components of the Fried Frailty Instrument are subjective in that they are patient-reported (exhaustion, physical activity and unintentional weight loss). Rather than confound the association between frailty and waitlist mortality, however, we believe that this ''subjectivity'' directly contributes to the association. For example, two patients with refractory ascites can perceive the burden of their ascites in different ways: one patient will spend most of his day in bed and report feeling ''exhausted'' (by the Fried Frailty Instrument), the other patient will pace the hospital hallways and not meet the same Fried Frailty criteria for ''exhausted.'' We hypothesize that the patient who perceives himself to be exhausted will restrict his physical activity leading to worsening sarcopenia, risk of infection and ultimately, increased vulnerability to waitlist mortality that exceeds his liver disease severity. Similarly, complications of cirrhosis such as massive ascites and poorly controlled encephalopathy will lead patients to reduce their physical activity and increase vulnerability to poor outcomes.
There is strong rationale for the application of frailty measures to a cirrhotic population who are typically younger than the geriatric population. First, cirrhosis is a state of accelerated physiologic aging. This is evidenced by the fact that 17% of liver transplant candidates in our study was categorized as frail by the Fried Frailty Instrument, a proportion that is commensurate to community-dwelling elderly individuals 80 years and older (8) . Second, the concept of frailty has already been applied to other similar conditions that can affect individuals in nongeriatric populations, such as end-stage renal disease (including renal transplant) and human immunodeficiency virus infection, and shown to predict clinically important outcomes such as long-term institutionalization, disability and mortality (21) (22) (23) (24) (25) . Last, two key pathophysiologic components of frailty-sarcopenia and decreased cardiopulmonary reserve-have been measured in liver transplant candidates and shown to be associated with transplant-related outcomes (26, 27) .
While we enrolled a large cohort that represents nearly the entire waitlist at UCSF with MELD ! 12, we acknowledge that there were relatively few deaths and delistings during our study period. This led to wide confidence intervals and uncertainty about the exact point estimate of the association and limited the ability to adjust for multiple confounders in our analyses. However, in our bi-and tri-variate models, the hazard ratios associated with each of the frailty measures remained remarkably similar to the univariate results, supporting our hypothesis that these frailty tools capture something other than the effects of the liver disease itself. In addition, all four measures of frailty revealed similar qualitative associations between increasing frailty and increased risk of waitlist mortality. Another potential limitation is that we did not include patients with MELD scores <12, a group for whom the frail phenotype may more accurately predict mortality compared with MELD score alone. This was intentional-to develop a cohort of patients who were theoretically just as likely to receive a transplant as experience death within the study follow-up period as well as achieve a sufficient number of waitlist events for our analyses.
Despite these limitations, our analyses have important conceptual and practical clinical implications. This is the first study to apply clinic-based measures of frailty to a population of liver transplant candidates. Frailty has already been applied and found to be highly prevalent in other solid organ transplant candidates including kidney (16, 22) and lung (28, 29) and predictive of transplant-related outcomes, supporting the utility of this geriatric concept in transplant hepatology. Although prior studies have shown that specific components of frailty, such as muscle mass (measured by quantitative morphomics (26)) and cardiopulmonary reserve (measured by cardiopulmonary exercise testing (27)), are predictive of transplant-related outcomes, all four of these frailty measures used in this study can be administered in a clinic setting within fewer than 10 min. Perhaps of greater clinical utility, patients with a MELD score (<18) and frail phenotype (by the Fried Frailty Instrument) experienced rates of waitlist mortality that were higher than those with MELD <18 and not frail or those with MELD ! 18. It is this subgroup (low MELD, high frailty) of patients who may derive the greatest benefit from implementation of these measures. Objective measurement of frailty can facilitate difficult conversations between transplant clinicians and the most debilitated candidates about their increased risk of waitlist mortality. Understanding this can motivate these patients to seek live donor transplantation or accept livers from a broadened spectrum of deceased donors. Last, we believe that the primary factor underlying the frail phenotype in cirrhotics-sarcopenia-may be reversible with physical therapy and nutritional support, and objective measures such as the Fried Frailty Instrument and Short Physical Performance Battery can be used to assess response to these interventions.
In summary, we have demonstrated in this study that the concept of frailty can be applied to liver transplant candidates and predict waitlist mortality even after adjustment for liver disease severity. Our next steps are to: (i) confirm these findings in a larger cohort with longer followup to better understand the complex relationship between frailty and liver disease severity and (ii) to determine whether these same measures before transplant can predict outcomes after transplant. Our data provide the justification to initiate a multi-center collaboration to evaluate the feasibility of applying these measures on a larger scale and evaluate their association with transplant outcomes. Ultimately, objective measurement of frailty in liver transplant candidates and a better understanding of the impact of frailty on their outcomes before and after transplant are critical to ensuring the timely, equitable and effective application of liver transplantation. 
